Effector T cells have a lower ligand affinity threshold for activation than naive T cells

被引:24
作者
Kimachi, K [1 ]
Sugie, K
Grey, HM
机构
[1] Chemosero Therapeut Res Inst, Kikuchi Lab, Kumamoto 8691298, Japan
[2] La Jolla Inst Allergy & Immunol, Div Immunochem, San Diego, CA 92121 USA
关键词
cellular differentiation; TCR antagonist;
D O I
10.1093/intimm/dxg087
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been previously established that effector and memory T cells are more sensitive to antigen stimulation than naive T cells. In this study, we compared the effect of ligand affinity on the activation of naive and effector T cells derived from pigeon cytochrome c (PCC)-specific TCR transgenic mice by stimulating these cells with a variety of ligands with widely differing antigenicity. The data obtained indicated the following. (i) The differences in antigen dose requirements for activation of naive and effector cells widened as the affinity of the antigen decreased. Most dramatically, peptides that were TCR antagonists for naive T cells were recognized as agonists by effector T cells. (ii) While both naive and effector T cells were activated by the bacterial superantigen staphylococcal enterotoxin A, specific for the transgenic TCR V(beta)3 chain, effector, but not naive, T cells were stimulated to proliferate by toxic shock syndrome toxin-1, a superantigen not previously described to be stimulatory for V(beta)3 T cells. (iii) Effector T cells, but not naive cells, proliferated in response to endogenous self-peptides presented by antigen-presenting cells in a syngeneic mixed lymphocyte reaction. Taken together these data indicate that effector T cells have a lower affinity threshold for activation than naive T cells. Further studies demonstrated that the heightened reactivity of effector T cells to low-affinity ligands declined progressively with repeated stimulations by antigen such that after repeated stimulation effector T cells were no longer stimulated by low-affinity ligands but recognized them as TCR antagonists similar to naive T cells.
引用
收藏
页码:885 / 892
页数:8
相关论文
共 42 条
[31]   ANTIGENS OF ACTIVATED RAT T LYMPHOCYTES INCLUDING A MOLECULE OF 50,000 MR DETECTED ONLY ON CD4 POSITIVE T-BLASTS [J].
PATERSON, DJ ;
JEFFERIES, WA ;
GREEN, JR ;
BRANDON, MR ;
CORTHESY, P ;
PUKLAVEC, M ;
WILLIAMS, AF .
MOLECULAR IMMUNOLOGY, 1987, 24 (12) :1281-1290
[32]   HUMAN-IMMUNODEFICIENCY-VIRUS GENETIC-VARIATION THAT CAN ESCAPE CYTOTOXIC T-CELL RECOGNITION [J].
PHILLIPS, RE ;
ROWLANDJONES, S ;
NIXON, DF ;
GOTCH, FM ;
EDWARDS, JP ;
OGUNLESI, AO ;
ELVIN, JG ;
ROTHBARD, JA ;
BANGHAM, CRM ;
RIZZA, CR ;
MCMICHAEL, AJ .
NATURE, 1991, 354 (6353) :453-459
[33]   Resting memory CD8(+) T cells are hyperreactive to antigenic challenge in vitro [J].
Pihlgren, M ;
Dubois, PM ;
Tomkowiak, M ;
Sjogren, T ;
Marvel, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2141-2151
[34]   Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway [J].
Reinhold, MI ;
Lindberg, FP ;
Kersh, GJ ;
Allen, PM ;
Brown, EJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :1-11
[35]   Qualitative changes accompany memory T cell generation: Faster, more effective responses at lower doses of antigen [J].
Rogers, PR ;
Dubey, C ;
Swain, SL .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2338-2346
[36]   CROSS-REACTIVITIES IN MEMORY CYTOTOXIC T-LYMPHOCYTE RECOGNITION OF HETEROLOGOUS VIRUSES [J].
SELIN, LK ;
NAHILL, SR ;
WELSH, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) :1933-1943
[37]   MULTIPLE HLA CLASS-I-DEPENDENT CYTOTOXICITIES CONSTITUTE THE NON-HLA-RESTRICTED RESPONSE IN INFECTIOUS-MONONUCLEOSIS [J].
STRANG, G ;
RICKINSON, AB .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (07) :1007-1013
[38]   The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope [J].
Wang, RF ;
Wang-Zhu, YR ;
Gabaglia, CR ;
Kimachi, K ;
Grey, HM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :983-993
[39]  
YANG H, 1986, J IMMUNOL, V136, P1186
[40]  
Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO